Home » Nevro Wins FDA Approval to Launch Spinal Stimulation Trial
Nevro Wins FDA Approval to Launch Spinal Stimulation Trial
Menlo Park, Calif.-based Nevro Corp. touted FDA approval to launch a pivotal clinical trial of its high-frequency spinal cord stimulation system in treatment of chronic pain.
Mass Device
Mass Device
Upcoming Events
-
07May
-
14May
-
30May